Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Iterum Therapeutics

Iterum Therapeutics
2015 FOUNDED
PUBLIC STATUS
31-40 EMPLOYEES
ITRM STOCK SYMBOL
$7.27 SHARE PRICE (As of Friday Closing)
Description

Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. The company's sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • Block 2 Floor 3, Harcourt Centre
  • Harcourt Street
  • Dublin 2
  • Ireland

+353 (01) 000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Iterum Therapeutics’s full profile, request a free trial.

Iterum Therapeutics Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$4.70 - $13.00 $108M $7.60 -$4.37 12.1K 14.2M

Iterum Therapeutics Financials Summary

In Thousands,
USD
TTM
30-Sep-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value (26,960)
Revenue 979 508 0
EBITDA (61,480) (29,174) (13,351)
Net Income (61,917) (29,406) (13,464)
Total Assets 116,865 46,757 26,917
Total Debt 14,541
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Iterum Therapeutics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Iterum Therapeutics‘s full profile, request access.

Request full access to PitchBook

Iterum Therapeutics Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Iterum Therapeutics‘s full profile, request access.

Request full access to PitchBook

Iterum Therapeutics Executive Team (8)

Name Title Board
Seat
Contact
Info
Corey Fishman Founder, President, Chief Executive Officer & Board Member
Judith Matthews Chief Financial Officer
Michael Dunne MD Chief Scientific Officer
Jeff Schaffnit Chief Commercial Officer
John White Vice President, Business Development & Supply Chain
You’re viewing 5 of 8 executives. Get the full list »

Iterum Therapeutics Board Members (11)

Name Representing Role Since Contact
Info
Corey Fishman Iterum Therapeutics Founder, President, Chief Executive Officer & Board Member 000 0000
David Kelly Iterum Therapeutics Board Member 000 0000
Paul Edick Self Chairman 000 0000

8 Former Board Members

You’re viewing 3 of 11 board members. Get the full list »